177
Views
1
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

Prevalence and antimicrobial susceptibility of Ureaplasma species and Mycoplasma hominis in Greek female outpatients, 2012–2016

, , , &

References

  • Waites KB, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Murray P, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of clinical microbiology. Washington, DC: American Society for Microbiology; 2007. p. 1004–20.
  • Taylor-Robinson D, Jensen JS. Genital mycoplasmas. In: Morse SA, Holmes KK, Moreland AA, Ballard RC, editors. Atlas of sexually trasmitted diseases and AIDS. Amsterdam: Elsevier; 2010. p. 64–71.
  • Patel MA, Nyirjesy P. Role of Mycoplasma and Ureaplasma species in female lower genital tract infections. Curr Infect Dis Rep. 2010;12(6):417–22.
  • Taylor-Robinson D. Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium. Res Microbiol. Forthcoming 2017. doi: 10.1016/j.resmic.2017.02.009.
  • Abele-Horn M, Scholz M, Wolff C, Kolben M. High density vaginal Ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery. Acta Obstet Gynecol Scand. 2000;79(11):973–8.
  • McCormack WM, Almeida PC, Bailey PE, Grady EM, Lee YH. Sexual activity and vaginal colonization with genital mycoplasmas. J Amer Med Assoc. 1972;221(12):1375–7.
  • Furr PM, Taylor-Robinson D. The effect of sex hormones on mycoplasmal genital infections. In: Stanek G, Zbl, editor. Recent advances in mycoplasmology (Suppl 20). Stuttgart: Gustav-Fischer Verlag; 1990. p. 223–6.
  • Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Non specific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74(1):14–22.
  • Zhu C, Liu J, Ling Y, Dong C, Wu T, Yu X, et al. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Chinese women with genital infectious diseases. Indian J Dermatol Venereol Leprol. 2012;78(3):406–7.
  • Kotrotsiou T, Exindari M, Diza E, Gioula G, Melidou A, Kaplanis K, et al. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum in asymptomatic women in Northern Greece. Hippokratia. 2013;17(4):319–21.
  • De Francesco MA, Caracciolo S, Bonfanti C, Manca N. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J Infect Chemother. 2013;19(4):621–7.
  • Skiljevic D, Mirkov D, Vukicevic J. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital. Indian J Dermatol Venereol Leprol. 2016;82(1):37–41.
  • Pónyai K, Mihalik N, Ostorházi E, Farkas B, Párducz L, Marschalkó M, et al. Incidence and antibiotic susceptibility of genital mycoplasmas in sexually active individuals in Hungary. Eur J Clin Microbiol Infect Dis. 2013;32(11):1423–6.
  • Guven MA, Gunyeli I, Dogan M, Ciragil P, Bakaris S, Gul M. The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum and the comparison of two medical regimens. Arch Gynecol Obstet. 2005;272(3):197–200.
  • Kouegnigan Rerambiah L, Ndong JC, Medzegue S, Elisee-Ndam M, Djoba Siawaya JF. Genital Mycoplasma infections and their resistance phenotypes in an African setting. Eur J Clin Microbiol Infect Dis. 2015;34(6):1087–90.
  • Díaz L, Cabrera LE, Fernández T, Ibáñez I, Torres Y, Obregón Y, et al. Frequency and antimicrobial sensitivity of Ureaplasma urealyticum and Mycoplasma hominis in patients with vaginal discharge. MEDICC Rev. 2013;15(4):45–7.
  • Liubin-Sternak S, Meštrović T. Chlamydia trachomatis and genital mycoplasmas: pathogens with an Impact on Human Reproductive Health. J Pathog. 2014;2014:183167.
  • Cunningham SA, Mandrekar JN, Rosenblatt JE, Patel R. Rapid PCR Detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum. Int J Bacteriol. 2013;2013:168742.
  • Petrikkos GL, Hadjisoteriou M, Daikos GL. PCR versus culture in the detection of vaginal Ureaplasma urealyticum and Mycoplasma hominis. Int J Gynaecol Obstet. 2007;97(3):202–3.
  • Iwasaka T, Wada T, Kidera Y, Sugimor H. Sugimor. Hormonal status and mycoplasma colonization in the female genital tract. Obstet Gynecol. 1986;68(2):263–6.
  • Al Farraj DA, Moubayed NM. The association between sociodemographic, hormonal, tubo-ovarian factors and bacterial count in Chlamydia and Mycoplasma infections with infertility. Saudi J Biol Sci. Forthcoming. 2016. doi: 10.1016/j.sjbs.2016.11.006.
  • Taylor-Robinson D, McCormack WM. The genital mycoplasmas. N Eng J Med. 1980;302(18):1003–10.
  • Hill GB. The microbiology of bacterial vaginosis. Am J Obstet Gynaecol. 1993;169(2Pt 2):450–4.
  • Rosenstein IJ, Morgan DJ, Sheehan M, Lamont RF, Taylor-Robinson D. Bacterial vaginosis in pregnancy: distribution of bacterial species in different gram-stain categories of the vaginal flora. J Med Microbiol. 1996;45(2):120–6.
  • Cox C, Watt AP, McKenna JP, Coyle PV. Mycoplasma hominis and Gardnerella vaginalis display a significant synergistic relationship in bacterial vaginosis. Eur J Clin Microbiol Infect Dis. 2016;35(3):481–7.
  • Kechagia N, Bersimis S, Chatzipanagiotou S. Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece. J Antimicrob Chemother. 2008;62(1):122–5.
  • Marekovic I, Matesa S, Skerk V, Begovac J, Tambic-Andrasevic A, Skerk V. Ureaplasma urealyticum and Mycoplasma hominis susceptibility to antimicrobial agents. J Chemother. 2007;19(4):465–6.
  • Bayraktar MR, Ozerol IH, Gucluer N, Celik O. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis. 2010;14(2):e90–5.
  • Wang QY, Li RH, Zheng LQ, Shang XH. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013. J Microbiol Immunol Infect. 2016;49(3):359–62.
  • Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18(4):757–89.
  • Ikonomidis A, Venetis C, Georgantzis D, Giaslakiotis V, Kolovos V, Efstathiou K, et al. Prevalence of Chlamydia trachomatis, Ureaplasma spp., Mycoplasma genitalium and Mycoplasma hominis among outpatients in central Greece: absence of tetracycline resistance gene tet(M) over a 4-year period study. New Microbes New Infect. 2015;9:8–10.
  • Furneri PM, Rappazzo G, Musumarra MP, Tempera G, Roccasalva LS. Genetic basis of natural resistance to erythromycin in Mycoplasma hominis. J Antimicrob Chemother. 2000;45(4):547–8.
  • Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect. 2010;16(11):1649–55.
  • Koh E, Kim S, Kim IS, Maeng KY, Lee SA. Antimicrobial susceptibilities of Ureaplasma urealyticum and Mycoplasma hominis in pregnant women. Korean J Clin Microbiol. 2009;12(4):159–62.
  • Karabay O, Topcuoglu A, Kocoglu E, Gurel S, Gurel H, Ince NK. Prevalence and antibiotic susceptibility of genital Mycoplasma hominis and Ureaplasma urealyticum in a university hospital in Turkey. Clin Exp Obstet Gynecol. 2006;33(1):36–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.